ARYA Sciences Acquisition Corp IV
ARYD · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $87 | $86 | $80 | $78 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $3 | $2 | $2 | $1 |
| Enterprise Value | $90 | $89 | $82 | $79 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | $0 | -$1 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$2 | -$0 | $0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.032 | -0.28 | -0.061 | 0.051 |
| % Growth | 88.7% | -356.8% | -219.3% | – |
| Operating Cash Flow | -$1 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$0 | -$0 | -$0 |